Skip to Main Content

Latest News

  • Paving the Way for Cancer Health Equity

    Since the appointment of Marcella Nunez-Smith, MD, MHS, as Director of the newly formed Center for Community Engagement and Health Equity (CEHE) within Smilow Cancer Hospital and Yale Cancer Center, the mission of ensuring cancer health equity and improving outcomes with an emphasis on traditionally marginalized communities, has begun to take shape.

    Read more
  • Chênevert Family Brain Tumor Center Launched at Yale

    Yale School of Medicine announces a gift to establish the Chênevert Family Brain Tumor Center at Yale Cancer Center. The Chênevert Family Brain Tumor Center will be a leading center in Neuro-Oncology research worldwide, bringing ground-breaking solutions and hope to patients with brain tumors.

    Read more
  • Taking a Dumbbell to Drug-Resistant Cancers

    The hope is that PROTACs can treat other “undruggable” cancers that don’t respond to current treatments, including types of lung, breast, and colorectal cancers that may not have an active site on which a small-molecule drug or monoclonal antibody could bind.

    Read more
  • A Pressing Need for New Ideas for Pancreatic Cancer

    Despite poor outcomes nationally and internationally, patients do better when they receive treatment at facilities like Smilow Cancer Hospital. Our unique ability to bring together clinicians and scientists focused on pancreatic cancer is propelling research advances and bringing renewed hope to patients.

    Read more
  • How COVID-19 is Transforming Smilow Cancer Hospital for the Future

    When COVID-19 surged in the spring of 2020, the physicians and staff who work in ambulatory care at Smilow Cancer Hospital and the Smilow Cancer Hospital Network were forced to respond with lightning speed, creating temporary spaces that would allow for social distancing, beefing up technology for relatively novel telehealth visits, and rethinking patient care to keep everyone safe.

    Read more